Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A
Posted: Thu Jul 14, 2022 1:41 pm
a) Tocilizumab
b) Itolizumab
c) Hemilizumab
d) Emicizumab
b) Itolizumab
c) Hemilizumab
d) Emicizumab